Recent immunotherapy Articles
Despite the remarkable progress in drug development across several populations of cancer, troubling facts have recently emerged about several expensive FDA-approved anticancer drugs.
It is widely acknowledged that 80% of our immune system resides in our gut. Therefore, healthy microbiota—bio-diverse gut flora comprised of healthy strains of bacteria—may offer a powerful key to preventing disease, including cancer. Turns out, a healthy microbiome may also significantly enhance the treatment outcomes of anticancer agents, most notably novel targeted immunotherapies.
We are hearing a lot about cancer immunotherapy these days. Modern approaches and technology are now helping to revolutionize cancer care. What decision-making power do we hold to influence an immune-therapeutic response to help avoid, manage, or treat a cancer diagnosis? And how might this affect long-term survival?